Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

By Huang Fang   Wu Xiao-Nan   Chen Jie   Wang Wen-Xiang   Lu ZuFu  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-06 ,pp. : 1611-1616

Spandidos Publications

Access to resources Recommend Favorite

cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance

By Villeneuve David   Hembruff Stacey   Veitch Zachary   Cecchetto Melanie   Dew William   Parissenti Amadeo  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 17-39

Springer Publishing Company

Access to resources Recommend Favorite

Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells

By          

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1692-1708

Spandidos Publications

Access to resources Recommend Favorite

A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression

By                

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 167-176

Spandidos Publications

Access to resources Recommend Favorite

Differentially expressed proteins in human breast cancer cells sensitive and resistant to paclitaxel

By          

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 822-830

Spandidos Publications

Access to resources Recommend Favorite